Cyclerion Therapeutics Inc (CYCN) — Financial Flexibility Index
Cyclerion Therapeutics Inc (CYCN) has a Financial Flexibility Index of -0.65x as of March 2026. Free cash flow of $-1.11 Million (operating CF $-1.18 Million minus capex $66.00K) represents -1% of total liabilities ($1.71 Million). Check CYCN PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Cyclerion Therapeutics Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Cyclerion Therapeutics Inc across 10 annual periods. See Cyclerion Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Cyclerion Therapeutics Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Cyclerion Therapeutics Inc. For the full company profile including market capitalisation, see Cyclerion Therapeutics Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.68x | $-3.31 Million | $-3.31 Million | $900.00K | ▲ +38.4% |
| 2024 | -5.98x | $-4.33 Million | $-4.33 Million | $725.00K | ▲ +41.3% |
| 2023 | -10.18x | $-21.25 Million | $-21.25 Million | $2.09 Million | ▼ -91.3% |
| 2022 | -5.32x | $-40.61 Million | $-40.61 Million | $7.63 Million | ▼ -61.7% |
| 2021 | -3.29x | $-36.51 Million | $-36.52 Million | $11.09 Million | ▼ -159.4% |
| 2020 | -1.27x | $-70.97 Million | $-72.49 Million | $55.88 Million | ▼ -18.2% |
| 2019 | -1.07x | $-95.33 Million | $-102.22 Million | $88.75 Million | ▲ +79.6% |
| 2018 | -5.27x | $-94.06 Million | $-97.50 Million | $17.85 Million | ▲ +7.3% |
| 2017 | -5.69x | $-79.81 Million | $-81.22 Million | $14.04 Million | ▼ -24.9% |
| 2016 | -4.55x | $-48.43 Million | $-49.87 Million | $10.64 Million | — |